Stay updated on Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Sign up to get notified when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.

Latest updates to the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedCore update: add a government funding status notice and update to v3.2.0; remove the old v3.1.0 tag. The new notice provides critical operational status, making it the primary change.SummaryDifference3%
- Check16 days agoChange DetectedUpdated version to v3.1.0 with new contact details (emails and phone numbers) and removal of the old version v3.0.2.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated to v3.0.2, indicating a minor update from v3.0.1. The 'Back to Top' navigation element has been removed, a minor navigation change.SummaryDifference0.2%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and various types of proteins and antibodies, while removing several specific terms related to locations and certain medical agents.SummaryDifference3%
- Check59 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ipilimumab and Nivolumab in Liver Resection Clinical Trial page.